Patient Leaflet Updated 07-Jun-2023 | Glenmark Pharmaceuticals Europe Ltd
Ropinirole 5 mg film-coated tablets
ROPINIROLE 5 mg film-coated tablets
Ropinirole
1. What ROPINIROLE is and what it is used for
2. What you need to know before you take ROPINIROLE
3. How to take ROPINIROLE
4. Possible side effects
5. How to store ROPINIROLE
6. Contents of the pack and other information
The active ingredient in ROPINIROLE 5 mg film-coated tablets is ropinirole, which belongs to a group of medicines called dopamine agonists. Dopamine agonists affect the brain in a similar way to a natural substance called dopamine.
ROPINIROLE is used to treat Parkinson’s disease.
People with Parkinson’s disease have low levels of dopamine in some parts of their brains. Ropinirole has effects similar to those of natural dopamine, so it helps to reduce the symptoms of Parkinson’s disease.
Tell your doctor if you think any of these may apply to you.
Tell your doctor or pharmacist before you start to taking ROPINIROLE if you:
Tell your doctor if you experience symptoms such as depression, apathy, anxiety, fatigue, sweating or pain after stopping or reducing your Ropinirole treatment (called dopamine agonist withdrawal syndrome or DAWS). If the problems persist more than a few weeks, your doctor may need to adjust your dose.
Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or an increase in sexual thoughts or feelings. Your doctor may need to adjust or stop your dose.
Tell your doctor if you or your family/carer notices that you are developing episodes of overactivity, elation or irritability (symptoms of mania). These may occur with or without the symptoms of impulse control disorders (see above). Your doctor may need to adjust or stop your dose.
Tell your doctor if you think any of these may apply to you. Your doctor may decide that ROPINIROLE isn’t suitable for you or that you need extra check-ups while you’re taking it.
Tell your doctor if you or your family notices that you are developing any unusual behaviours (such as an unusual urge to gamble or increased sexual urges and/or behaviours) while you are taking Ropinirole. Your doctor may need to adjust or stop your dose.
Tell your doctor if you start smoking, or give up smoking, while you are taking Ropinirole.
Your doctor may need to adjust your dose.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines including any herbal medicines or other medicines you obtained without a prescription.
Some medicines can affect the way ROPINIROLE works, or make it more likely that you will have side effects. ROPINIROLE can also affect the way some other medicines work. These include:
Tell your doctor if you are taking, or have recently taken any of these medicines.
You will require additional blood tests if you are taking these medicines with ROPINIROLE:
If you take this medicine with food, you may be less likely to feel sick (nauseous) or be sick (vomit). So it’s best to take it with food if you can.
ROPINIROLE is not recommended if you are pregnant, unless your doctor advises that the benefit to you taking ROPINIROLE is greater than the risk to your unborn baby.
ROPINIROLE is not recommended if you are breast feeding, as it can affect your milk production.
If you are pregnant or breast-feeding, think you may be pregnant or planning to have a baby,ask your doctor or pharmacist for advice before taking this medicine. Your doctor may advise you to stop taking ROPINIROLE.
ROPINIROLE can make you feel drowsy. It can make people feel extremely sleepy and it sometimes makes people fall asleep very suddenly without warning.
Ropinirole can cause hallucinations (seeing, hearing or feeling things that are not there). If affected do not drive or use machines.
If you could be affected: do not drive, do not operate machines and do not put yourself in any situation where feeling sleepy or falling asleep could put you (or other people) at risk of serious injury or death. Do not take part in these activities until you are no longer affected.
Talk to your doctor if this causes problems for you.
ROPINIROLE tablets contains a small amount of a sugar called lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking ROPINIROLE.
ROPINIROLE tablets contain less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium-free”.
This medicinal product contains lactose. If you have an intolerance to lactose or any other sugars, ask your doctor for advice before you take this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
You may be given ROPINIROLE on its own to treat the symptoms of your Parkinson’s disease, or you may be given ROPINIROLE as well as another medicine called L-dopa (also called levodopa).
Do not give ROPINIROLE to children. ROPINIROLE is not normally precribed for people under 18.
It may take a while to find out the best dose of ROPINIROLE for you.
The usual starting dose is 0.25 mg of ropinirole three times each day for the first week. Then your doctor will increase your dose each week, for the next three weeks.
After that, your doctor will gradually increase the dose until you are taking the dose that is best for you. The usual dose is 1 mg to 3 mg three times each day (making a total daily dose of 3 mg to 9 mg). If your Parkinson’s disease symptoms have not improved enough, your doctor may decide to gradually increase your dose some more.
Some people take up to 8 mg of ROPINIROLE three times a day (24 mg daily altogether).
If you are also taking other medicines for Parkinson’s disease, your doctor may advise you to gradually reduce the dose of the other medicine. If you are taking L-dopa you may experience some uncontrollable movements (dyskinesias) when you first start taking Ropinirole. Tell your doctor if this happens, as your doctor may need to adjust the doses of the medicines you are taking.
Do not take any more ROPINIROLE than your doctor has recommended.
It may take a few weeks for ROPINIROLE to work for you.
Take ROPINIROLE three times a day.
Swallow the ROPINIROLE tablet(s) whole with a glass of water. It is best to take ROPINIROLE with food, because that makes it less likely that you will feel sick (nauseous).
Contact a doctor or pharmacist immediately. If possible, show them the ROPINIROLE pack.
Someone who has taken an overdose of ROPINIROLE may have any of these symptoms: feeling sick (nausea) or being sick (vomiting), dizziness (a spinning sensation), feeling drowsy, mental or physical tiredness, fainting and hallucinations.
Do not take extra tablets or a double dose to make up for a missed dose. Just take your next dose at the usual time.
If you have missed taking ROPINIROLE for one day or more, ask your doctor for advice on how to start taking ROPINIROLE again.
Do not stop taking ROPINIROLE without advice.
Take Ropinirole for as long as your doctor recommends. Do not stop unless your doctor advises you to.
If you suddenly stop taking Ropinirole, your Parkinson’s disease symptoms may quickly get much worse.
A sudden stop could cause you to develop a medical condition called neuroleptic malignant syndrome which may represent a major health risk. The symptoms include: akinesia (loss of muscle movement), rigid muscles, fever, unstable blood pressure, tachycardia (increased heart rate), confusion, depressed level of consciousness (e.g. coma ).
If you need to stop taking ROPINIROLE your doctor will reduce your dose gradually.
If you have any further questions on the use of this medicine , ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
The side effects of ROPINIROLE are more likely to happen when you first start taking it, or when your dose has just been increased. They are usually mild, and may become less troublesome after you have taken the dose for a while.
If you are worried about side effects, talk to your doctor.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
You may experience the following side effects:
Tell your doctor if you experience any of these behaviours; they will discuss ways of managing or reducing the symptoms.
People who are taking ROPINIROLE with L-dopa may develop other side effects over time:
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister/bottle and the outer carton after Exp. The expiry date refers to the last day of that month.
Do not store above 30°C.
Blisters:
Store in the original package in order to protect from moisture.
Bottles:
Keep the bottle tightly closed in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The other ingredients are:
Tablet Cores
Lactose, Anhydrous
Lactose Monohydrate
Cellulose, microcrystalline (E460)
Citric acid, anhydrous (E330)
Croscarmellose sodium (E468)
Magnesium Stearate (E572)
Film Coating
5 mg Hypromellose (E464), Titanium dioxide (E171), Macrogol 400, Talc, Indigo carmine aluminium lake (E132), Brilliant blue FCF Aluminium lake (E133)
Film-coated tablet.
5 mg Blue, circular, bevelled edged, biconvex film coated tablets with ‘259’ debossed on one side and ‘G’ on the other side.
The tablets are packed in either plain Aluminium/Aluminium blisters, white, opaque Triplex (PVC/PE/Aclar)/Aluminium blisters or white opaque HDPE bottles with polypropylene child-resistant closure
Pack Sizes
Blister: 21 and 84
Bottle: 84
Not all pack sizes may be marketed.
This leaflet was last revised in 06/2023.
Building 2, Croxley Park, Watford, WD18 8YA
+44 (0)1923 251137
www.glenmarkpharma.com
+44 (0)1923 202 950
0800 458 0383
+44 (0)1923 202 950